Search Orphan Drug Designations and Approvals
-
Generic Name: | (S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile |
---|---|
Date Designated: | 01/05/2017 |
Orphan Designation: | Treatment of epidermolysis bullosa acquisita |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 03/15/2018 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Almirall, S.A. Ctra. Laurea Miro, 408-410 Sant Feliu de Llobregat Barcelona, Catalunya Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-